Geriatric Palliative Care
Jessica Israel
R. Sean Morrison
In our society, the overwhelming majority of people who die are elderly. They typically die slowly of chronic diseases, over long periods of time, with multiple coexisting problems, progressive dependency on others, and heavy care needs met mostly by family members. They spend most of their final months and years at home but, in most parts of the country, actually die surrounded by strangers in the hospital or nursing home. Abundant evidence suggests that the quality of life during the dying process is often poor, characterized by inadequately treated physical distress, fragmented care systems, poor to absent communication between doctors and patients and families, and enormous strains on family caregiver and support systems. In this chapter, we focus on the palliative care needs of older adults.
Biology of Aging
Body Composition
Aging is a process that converts healthy adults into frail ones with diminished reserves in most physiologic systems and with an exponentially increasing vulnerability to most diseases and death (1). Aging is the most significant and common risk factor for disease in general. The process itself is a mystery, still poorly understood even in this age of advanced biotechnologic capability. Normal aging appears to be a fairly benign process. The body’s organ system reserves and homeostatic control mechanisms steadily decline. Commonly, this slow erosion only becomes obvious in times of maximum body stress or serious illness. However, as the process continues, it takes less and less insult for the underlying physiologic weakness to become apparent. It is difficult to differentiate the effects of aging alone from those of concurrent disease or environmental factors. Eventually, a critical point is reached, when the body’s systems are overwhelmed, and death ultimately results. Morbidity is often compressed into the last period of life (2).
Substantial changes occur in body composition with aging. These changes become important when related to nutritional needs, pharmacokinetics, and metabolic activity. As adults age, the proportion of bodily lipid doubles and lean body mass decreases. Bones and viscera shrink and the basal metabolic rate declines. Although specific age-associated changes occur in each organ system, changes in body composition and metabolism are highly variable from individual to individual.
Renal Function
The aging kidney loses functioning nephrons. Cross-sectional and longitudinal studies have also demonstrated a decline in creatinine clearance. There is also evidence to show decreased renal plasma flow, decreased tubular secretion and reabsorption, decreased hydrogen secretion and decreased water absorption and excretion (3). When kidney disease complicates this aging process, the outcome can be highly deleterious.
Underlying renal function is an important issue in geriatric pharmacology. Many medications rely on the kidneys’ mechanisms for excretion and their metabolites may accumulate and lead to side effects or toxic injury in an impaired system. For example, the renally cleared metabolite of meperidine, normeperidine, can accumulate in the elderly and predispose to delirium, central nervous system excitement, and seizure activity. Commonly used medications are more likely to damage older kidneys, including nonsteroidal anti-inflammatory drugs (NSAIDs), aminoglycosides, and intravenous contrast dye (4).
Gastrointestinal and Hepatic Function
The gastrointestinal tract changes less with aging than normal systems, but there are still some deficiencies that may affect medication delivery and breakdown, as well as nutritional status and metabolism. The esophagus may show delayed transit time. The stomach may atrophy and produce less acid. Colonic transit is greatly slowed, whereas small intestinal transit appears unaffected. Pancreatic function is usually well maintained, although trypsin secretion may be decreased.
The liver usually retains adequate function, although there are variable changes seen in its metabolic pathways. The cytochrome P-450 system may decline in efficiency and liver enzymes may be less inducible. The most significant change is the sharp decline in demethylization, the process that metabolizes medications such as benzodiazepines in the liver. This change may necessitate dosage adjustments. In addition, drugs that undergo hepatic first pass metabolism by extraction from the blood may have altered clearance with increasing age because of decreased hepatic blood flow.
Brain and Central Nervous System Changes
The brain and central nervous system slowly atrophy with age. Neurons stop proliferating and are not replaced when they die, resulting in neuronal loss as well as loss of dendritic arborization. These are also some degree of neurotransmitter and receptor loss. The extent of this loss is not well understood.
Age-related changes in pain perception may exist, but their clinical importance is uncertain. Although degenerative changes occur in areas of the central and autonomic nervous system that mediate pain, the relevance of these changes has yet to be determined (5). Clinical observations from elderly patients who report minimal pain and discomfort despite the presence of cardiac ischemia or intraabdominal catastrophe suggest that pain perception may be altered in the elderly. However, experimental data suggest that significant, age-related changes in pain perception probably do not occur (6). Until further studies conclusively demonstrate that the perception of pain decreases with age, stereotyping of most elderly patients as experiencing less pain may lead to inaccurate clinical assessments and needless suffering (5).
Demography of Dying and Death in the United States
The median age at death in the United States is now 77 years and has been associated with a steady and linear decline in age-adjusted death rates since 1940. In 1900, life expectancy at birth was <50 years; a girl born today may expect to live to age 79 and a boy to age 73. Those reaching 65 years can expect to live another 18 years on average and those reaching age 80 can expect to live an additional 8 years. These unprecedented increases in life expectancy (equivalent to that occurring between the Stone Age and 1900) are due primarily to decreases in maternal and infant mortality, resulting from improved sanitation, nutrition, and effective control of infectious diseases. As a result, there has been an enormous growth in the number and health of the elderly. By the year 2030, 20% of the United States’ population will be over age 65, as compared to fewer than 5% at the turn of the twentieth century (7).
Although death at the turn of the twentieth century was largely attributable to acute infectious diseases or accidents, the leading causes of death today are chronic illness such as heart disease, cancer, stroke, and dementia. With advances in the treatment of atherosclerotic vascular disease and cancer, many patients with these diseases now survive for years. Many diseases that were rapidly fatal in the past have now become chronic illnesses.
In parallel, deaths that occurred at home in the early part of the twentieth century now occur primarily in institutions (57% in hospitals and 17% in nursing homes) (8). The reasons for this shift in location of death are complex, but appear to be related to health system and reimbursement structures that promote hospital-based care and provide relatively little support for home care and custodial care services despite the significant care burdens and functional dependency that accompany life-threatening chronic disease in the elderly. The older the patient, the higher the likelihood of death in a nursing home or hospital, with an estimated 58% of persons over 85 spending at least some time in a nursing home during the last year of their life (8). These statistics, however, hide the fact that most of an older person’s last months and years is still spent at home in the care of family members, with hospitalization and/or nursing home placement occurring only near the very end of life. National statistics also obscure the variability in the experience of dying. For example, the need for institutionalization or paid formal caregivers in the last months of life is much higher among the poor and women. Similarly, persons suffering from cognitive impairment and dementia are much more likely to spend their last days in a nursing home compared with cognitively intact, elderly persons dying from nondementing illnesses.
Care Systems for Older Adults with Serious and Life-Threatening Illness
The incentives promoting an institutional—as opposed to home—death persist despite evidence that patients prefer to die at home. These incentives persist in the United States despite the existence of the Medicare Hospice Benefit (9), which was designed to provide substantial professional and material support (medications, equipment, skilled nursing visits) to families caring for the dying at home for their last 6 months of life. Reasons for the low rate of utilization of the Medicare Hospice Benefit vary by community but include the inhibiting requirements that patients acknowledge that they are dying in order to access the services, that physicians certify a prognosis of 6 months or less, and that very few hours (usually 4 or less) of personal care home attendants are covered under the benefit. In addition, the fiscal structure of the Medicare Hospice Benefit lends itself well to the predictable trajectory of late-stage cancers or acquired immunodeficiency syndrome (AIDS), but not so well to the unpredictable chronic course of other common causes of death in the elderly such as congestive heart failure, chronic lung disease, stroke, and dementing illnesses.
Traditional Medicare coverage in the United States also fails to meet the needs of the seriously ill, older adult. Neither paid personal care services at home nor nursing home costs for the functionally dependent elderly are covered by Medicare, but instead are paid for approximately equally from out-of-pocket and Medicaid budgetary sources that were originally developed to provide care for the indigent.
In nursing homes, standards of care focus on improvement of function, and maintenance of weight and nutritional status. Evidence of the decline that accompanies the dying process is typically regarded as a measure of substandard care (10). Therefore, a death in a nursing home is often viewed as evidence particularly by state regulators; of poor care rather than an expected outcome for a frail, chronically ill, older person. The financial and regulatory incentives and quality measures that currently exist in long-term care promote tube feeding over spoon feeding and transfer to hospital or emergency department in the setting of acute illness or impending death. They fail to either assess or reward appropriate attention to palliative measures, including relief of symptoms, spiritual care, and promotion of continuity with concomitant avoidance of brink-of-death emergency room and hospital transfers (11) (Table 74.1).
Table 74.1 Benefits and Risks of Tube Feeding in Older Adults/Nursing Home Residents | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Palliative Care Needs of Older Adults
Although death occurs far more commonly in older adults than in any other age group, remarkably little is known about how death occurs in the oldest old, those over age 75. Most research on the experience of dying has been done in younger populations, and most studies examining pain and symptom management have focused on younger populations with cancer or AIDS. Studies in older adults have focused
primarily on patients’ preferences for care rather than the actual care received. Indeed, the largest study to date of the dying experience in the United States [study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT)] studied the hospital experience of patients with a median age of 66 (9). The median age of death in the United States is 77 years, and many of the oldest old die in nursing homes or at home rather than in hospital. Data from Medicare and state Medicaid registries suggest that expensive and high technology interventions are less frequently applied to the oldest patients, independent of functional status and projected life expectancy. Whereas these discrepancies may reflect patient preferences and indicate appropriate utilization of resources and patient preferences, it is more likely that they represent a form of implicit rationing of resources based on age. The implication is disturbing, considering that half of the highest-cost, Medicare enrollees survive at least 1 year (12).
primarily on patients’ preferences for care rather than the actual care received. Indeed, the largest study to date of the dying experience in the United States [study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT)] studied the hospital experience of patients with a median age of 66 (9). The median age of death in the United States is 77 years, and many of the oldest old die in nursing homes or at home rather than in hospital. Data from Medicare and state Medicaid registries suggest that expensive and high technology interventions are less frequently applied to the oldest patients, independent of functional status and projected life expectancy. Whereas these discrepancies may reflect patient preferences and indicate appropriate utilization of resources and patient preferences, it is more likely that they represent a form of implicit rationing of resources based on age. The implication is disturbing, considering that half of the highest-cost, Medicare enrollees survive at least 1 year (12).
Aside from pain and other sources of physical distress [discussed in the subsequent text (see the section Symptom Management: The Challenge of Pain)], the key characteristic that distinguishes the dying process in the elderly from that experienced by younger groups is the nearly universal occurrence of long periods of functional dependency and need for family caregivers in the last months to years of life. In SUPPORT, the median age of participants was 66 years and 55% of patients had persistent and serious family caregiving needs during the course of their terminal illness (13), and in another study of 988 terminally ill patients, 35% of families had substantial care needs (14). This percentage rises exponentially with increasing age. Although paid care supplements provides the sole source of care in 15–20% of patients (transportation, homemaker services, personal care, and more skilled nursing care), the remaining 80–85% of patients receive most of their care from unpaid family members (14). Furthermore, most family caregiving is provided by women (spouses and adult daughters and daughters-in-law), placing significant strains on the physical, emotional, and socioeconomic status of the caregivers. Those ill and dependent patients without family caregivers, or those whose caregivers can no longer provide nor afford needed services, are placed in nursing homes. In the United States, this typically occurs after patients exhaust all of their financial savings in order to become eligible for Medicaid. At present, 20% of the over age 85 population reside in a skilled nursing facility, and this number is expected to increase dramatically in the next 50 years (15). Present estimates suggest the current number of skilled nursing facility beds in the United States will be woefully inadequate for the needs of our aging population.
Symptom Management: The Challenge of Pain
The constellation of symptoms seen in dying, older, adult patients is different from that of young adults. Delirium, sensory impairment, incontinence, dizziness, cough, and constipation are more prevalent in older adults (16). The elderly, on average, have 1.5 more symptoms than younger persons in the year prior to death, and 69% of the symptoms reported for people aged 85 or more lasted more than a year as compared with 39% of those for younger adults (<55 years) (16).